Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Assets Average (2016 - 2026)

Amphastar Pharmaceuticals has reported Assets Average over the past 12 years, most recently at $1.6 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 5.54% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 5.54%, while the annual FY2025 figure was $1.6 billion, 3.77% up from the prior year.
  • Assets Average for Q4 2025 was $1.6 billion at Amphastar Pharmaceuticals, roughly flat from $1.6 billion in the prior quarter.
  • Over five years, Assets Average peaked at $1.6 billion in Q4 2025 and troughed at $638.5 million in Q1 2021.
  • A 5-year average of $1.1 billion and a median of $1.3 billion in 2023 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: surged 108.18% in 2023 and later rose 2.13% in 2024.
  • Year by year, Assets Average stood at $661.6 million in 2021, then grew by 10.99% to $734.3 million in 2022, then surged by 108.18% to $1.5 billion in 2023, then grew by 2.13% to $1.6 billion in 2024, then increased by 5.54% to $1.6 billion in 2025.
  • Business Quant data shows Assets Average for AMPH at $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.